FDA inspection
CellTrans Inc.: FDA inspection ending Jan 16, 2024
FDA inspection 1228629 · No Action Indicated (NAI) · Chicago, IL
Key facts
| Inspection ID | 1228629 |
|---|---|
| Firm | CellTrans Inc. |
| FEI number | 3019202665 |
| Address | 1740 W Taylor St Bldg 949 Ste C200 |
| City | Chicago |
| State | IL |
| ZIP | 60612 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Jan 16, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data